Sientra Inc (NASDAQ:SIEN) Shares Bought by Millennium Management LLC

Millennium Management LLC raised its stake in Sientra Inc (NASDAQ:SIEN) by 97,855.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 3,242,332 shares of the medical instruments supplier’s stock after acquiring an additional 3,239,022 shares during the period. Millennium Management LLC owned 0.07% of Sientra worth $21,010,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Bailard Inc. raised its stake in shares of Sientra by 28.9% during the second quarter. Bailard Inc. now owns 25,000 shares of the medical instruments supplier’s stock worth $154,000 after purchasing an additional 5,600 shares during the last quarter. Granite Point Capital Management L.P. raised its position in Sientra by 15.3% during the 2nd quarter. Granite Point Capital Management L.P. now owns 1,014,898 shares of the medical instruments supplier’s stock worth $6,252,000 after buying an additional 134,898 shares during the last quarter. Kornitzer Capital Management Inc. KS purchased a new position in Sientra during the 2nd quarter worth $462,000. Stephens Inc. AR raised its position in Sientra by 81.1% during the 2nd quarter. Stephens Inc. AR now owns 254,832 shares of the medical instruments supplier’s stock worth $1,570,000 after buying an additional 114,132 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Sientra by 127.1% in the 2nd quarter. Wells Fargo & Company MN now owns 52,594 shares of the medical instruments supplier’s stock worth $324,000 after acquiring an additional 29,430 shares during the period. Institutional investors own 89.76% of the company’s stock.

Sientra stock opened at $8.39 on Tuesday. Sientra Inc has a one year low of $4.78 and a one year high of $18.67. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.32 and a current ratio of 2.80. The business has a fifty day moving average of $7.44 and a two-hundred day moving average of $6.65. The company has a market cap of $423.56 million, a P/E ratio of -2.58 and a beta of 0.36.

Sientra (NASDAQ:SIEN) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported ($0.45) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.02. Sientra had a negative net margin of 143.76% and a negative return on equity of 122.95%. The company had revenue of $22.41 million for the quarter, compared to analyst estimates of $20.05 million. During the same period in the previous year, the firm earned ($0.72) EPS. The business’s revenue was up 32.8% on a year-over-year basis. Sell-side analysts predict that Sientra Inc will post -1.94 EPS for the current year.

SIEN has been the topic of several analyst reports. William Blair raised shares of Sientra from a “market perform” rating to an “outperform” rating in a report on Tuesday, November 5th. ValuEngine raised shares of Sientra from a “hold” rating to a “buy” rating in a report on Wednesday, October 2nd. Stephens set a $16.00 price objective on shares of Sientra and gave the company a “buy” rating in a research report on Friday, August 9th. Canaccord Genuity set a $13.00 price objective on Sientra and gave the company a “buy” rating in a report on Tuesday, September 24th. Finally, Zacks Investment Research upgraded Sientra from a “hold” rating to a “buy” rating and set a $9.25 target price on the stock in a research report on Saturday, November 23rd. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. Sientra presently has an average rating of “Buy” and a consensus price target of $15.03.

About Sientra

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Article: Options Trading – Understanding Strike Price

Want to see what other hedge funds are holding SIEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sientra Inc (NASDAQ:SIEN).

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.